Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 48349701000001114 | Floxapen (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 48349801000001117 | Floxapen | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Floxapen | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Floxapen 250mg/5ml syrup (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 125mg/5ml syrup (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 500mg powder for solution for injection vials (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 250mg capsules (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 1g powder for solution for injection vials (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 250mg powder for solution for injection vials (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier | |
| Floxapen 500mg capsules (GlaxoSmithKline) | Is a | True | Floxapen | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR